Peiming Guo

Jinan Central Hospital

Papers

1

Total Citations

4

H-Index

1

About

Peiming Guo is a clinical researcher specializing in gastrointestinal oncology, with a particular focus on optimizing perioperative care for patients undergoing advanced gastric cancer surgery. Their work bridges surgical oncology and microbiome science, investigating how probiotic supplementation can improve outcomes for patients receiving neoadjuvant chemotherapy prior to laparoscopic or robotic radical gastrectomy. Guo's most notable contribution is the design of the GISSG2023-01 multicenter randomized controlled trial, a protocol study that has already garnered 4 citations since its 2025 publication. This work addresses a critical gap in understanding how gut microbiome modulation might mitigate chemotherapy-related complications and enhance surgical recovery in advanced gastric cancer patients. By integrating neoadjuvant treatment protocols with innovative perioperative interventions, Guo is helping to shape evidence-based strategies that could improve both short-term clinical outcomes and long-term prognoses for this challenging patient population. Their research represents an important step toward personalized, multimodal approaches in gastric cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG2023 - 01 Study)
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: Jinan Central Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago